CYP1B1 and glioblastoma: To further confirm the effects of these compounds on AhR in human glioblastoma, the expression of the AhR downstream gene CYP1B1 was investigated after being treated with different concentrations of evodiamine, dehydroaevodiamine, and rutaecarpine.